HOXA5 safeguards against atherosclerosis via peroxisome proliferator-activated receptor gamma (PPARγ), whereas HOXB9 exacerbates inflammation through bone morphogenetic protein 4-tumor necrosis factor (BMP4-TNF). Here, BMP4 is linked to atherosclerosis.